The modern state of orally disintegrating tablets development
DOI:
https://doi.org/10.24959/170227Keywords:
orally disintegrating tablets, pharmaceutical development, taste masking, disintegrationAbstract
Topicality. Orally disintegrating tablets (hereinafter ODT) represent the modern direction of solid dosage form development. Due to the rapid disintegration in a small amount of liquid, ODT are characterized by better bioavailability, ease of use and less toxic effects of active pharmaceutical ingredients (API) on the liver owing to reducing the first-pass metabolism.
Aim. To analyze literary sources regarding the current state of pharmaceutical development of this dosage form.
Materials and methods. Analysis of scientific bases of literary sources such as: PubMed, ResearchGate, Academia. edu, Scopus, etc.
Results and discussion. The development of drugs in the form of ODT suggests taking into account certain requirements for this dosage form: sufficient mechanical strength along with rapid disintegration in a small amount of liquid, pleasant tactile and taste sensations, the choice of optimal packaging. The achievement of the optimal strength and disintegration is possible by using two methods – adding excipients (first of all, fillers, binders and superdisintegrators) and selecting the pressure on a tablet machine. Satisfactory tactile and taste sensations of the ODT are provided by masking the taste of API through addition of flavors, taste correctives and physical and chemical methods. The choice of one or another type and material of the packaging is determined by the physical and chemical properties of the API.
Conclusions. Despite the fact that ODT drugs belong to tableted dosage forms, they have certain specific differences from traditional tablets. Therefore, their pharmaceutical development involves especial approaches and tests that are necessary for the successful realization of this dosage form advantages
References
Kovalevskaja, E. G. (2014). Optimizacija uslovij proizvodstva substancii digidrokvercetina, razrabotka lekarstvennogo preparata na ee osnove. Candidate’s thesis. Pjatigorsk, 144.
Guidance for Industry Orally Disintegrating Tablets. (2008). U.S. Department of Health and Human Services Food and Drug Administration. Available at :
https://www.fda.gov/downloads/Drugs/.../Guidances/ucm070578.pdf.
Tabletky, shcho dysperhuiutsia. (2018). Derzhavna farmakopeia Ukrainy. Kharkiv : Derzhavne pidpryiemstvo “Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv”.
Amin, A. F. (2005). Emerging trends in orally disintegrating tablets. Available at : www.pharminfo.net
Preethi, S. (2013). Oral dispersible tablet – an overview. Int. J. Inv. Pharm. Sci, 1 (5), 438–447.
Arora, P., Sethi, V. A. (2013). Orodispersible tablets: a comprehensive review. International Journal of Research and Development in Pharmacy and Life Sciences, 2, 270–284.
Pabari, R. M., & Ramtoola, Z. (2012). Effect of a Disintegration Mechanism on Wetting, Water Absorption, and Disintegration Time of Orodispersible Tablets. Journal of Young Pharmacists, 4 (3), 157–163. https://doi.org/10.4103/0975-1483.100021
Tekhnolohiya likiv promyslovoho vyrobnytstva. (2012). Kharkiv : NFaU, 694.
Douroumis, D. (2011). Orally disintegrating dosage forms and taste–masking technologies; 2010. Expert Opinion on Drug Delivery, 8 (5), 665–675. https://doi.org/10.1517/17425247.2011.566553
Sandri, G., Bonferoni, M. C., Ferrari, F., Rossi, S., & Caramella, C. (2006). Differentiating Factors between Oral Fast-Dissolving Technologies. American
Journal of Drug Delivery, 4 (4), 249–262. https://doi.org/10.2165/00137696-200604040-00007
Wehling, F., Schuehle, S., Madamala, N. (1993). US Patent 5, 178, 878.
Remya, K. S., Beena, P., Bijesh, P. V., & Sheeba, A. (2010). Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants
in Cefixime Oral Disintegrating Tablets. Journal of Young Pharmacists, 2 (3), 234–239. https://doi.org/10.4103/0975-1483.66794
Battu, S. K., Repka, M. A., Majumdar, S., & Rao Y, M. (2007). Formulation and Evaluation of Rapidly Disintegrating Fenoverine Tablets: Effect of
Superdisintegrants. Drug Development and Industrial Pharmacy, 33 (11), 1225–1232. https://doi.org/10.1080/03639040701377888
Fukami, J., Yonemochi, E., Yoshihashi, Y., & Terada, K. (2006). Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.
International Journal of Pharmaceutics, 310 (1-2), 101–109. https://doi.org/10.1016/j.ijpharm.2005.11.041
Jacob, S., Shirwaikar, A., & Nair, A. (2009). Preparation and Evaluation of Fast–Disintegrating Effervescent Tablets of Glibenclamide. Drug Development
and Industrial Pharmacy, 35 (3), 321–328. https://doi.org/10.1080/03639040802337021
LATE, S., YU, Y., & BANGA, A. (2009). Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets. International Journal of Pharmaceutics, 365 (1-2), 4–11. https://doi.org/10.1016/j.ijpharm.2008.08.010
Shah, U., & Augsburger, L. (2002). Multiple Sources of Sodium Starch Glycolate, NF: Evaluation of Functional Equivalence and Development of Standard Performance Tests. Pharmaceutical Development and Technology, 7 (3), 345–359. https://doi.org/10.1081/pdt-120005731
Bhowmik, D., Chiranjib, B., Pankaj, K., Chandira, K. (2009). Fast Dissolving Tablet : An Overview. Journal of Chemical and Pharmaceutical Research, 1 (1). 163–177.
Khinchi, M., Bhandari, A., Sharma, N., Sharma, N., Agarwal, D. (2011). Design and development of orally disintegrating tablets of famotidine prepared by direct compression method using different super-disintegrants. Journal of Applied Pharmaceutical Science, 1, 50–58.
Bi, Y. X., Sunada, H., Yonezawa, Y., & Danjo, K. (1999). Evaluation of Rapidly Disintegrating Tablets Prepared by a Direct Compression Method. Drug Development and Industrial Pharmacy, 25 (5), 571–581. https://doi.org/10.1081/ddc-100102211
Rajpurohit, H., Sharma, P., Sharma, S., Purohit, S., & Bhandari, A. (2011). Hordeum Vulgare Hull in the Design of Fast Disintegrating Tablets. Journal of Young Pharmacists, 3 (3), 211–215. https://doi.org/10.4103/0975-1483.83763
Tripathi, A., Parmar, D., Upendra, P., Ghanshyam, Patel., Daslaniya, D., Bhimani, B. (2011). Taste Masking : A Novel Approach for Bitter and Obnoxious Drugs. Journal of Pharmaceutical science and bioscientific research, 1 (3), 136–142.
Kuznecov, A. V., Kuznecov, A. M., Shevchenko, L. S. (2015). Sovremennye problemy nauki i obrazovanija. Available at : https://www.science-education.ru/ru/article/view?id=22305
Coupland, J. N., & Hayes, J. E. (2014). Physical Approaches to Masking Bitter Taste: Lessons from Food and Pharmaceuticals. Pharmaceutical Research,
(11), 2921–2939. https://doi.org/10.1007/s11095-014-1480-6
Shet, N., Vaidya, I. (2013). Taste Masking : A Pathfinder for Bitter Drugs. International Journal of Pharmaceutical Sciences Review and Research.
Available at : http://www.globalresearchonline.net/journalcontents/v18-2/01.pdf
Gupta, K., Madaan, S., Dalal, S. (2010). Practical Approaches for Taste Masking of Bitter Drug: A Review. International Journal of Drug Delivery Technology.
Available at : https://www.myresearchjournals.com/index.php/IJDDT/article/view/8848/8144
Ahire, S., Bankar, V., Gayakwad, P. (2012). A review: taste masking techniques in pharmaceuticals. International Journal of Pharmaceutical Sciences,
(1), 68–82.
Thoke, S., Amol, G., Rahul, D., Puranik, P., Yogesh, S. (2012). Review On: Taste masking approaches and Evaluation of Taste Masking. International
Journal of Pharmaceutical Sciences, 3 (1), 1895–1907.
Dhokne, S. (2018). Pharmaceutical Packaging tablet and capsules. Available at : https://www.slideshare.net/GirishSahu13/pharmaceutical-packagingtablet-and-capsules
Dean, D., Evans, E., Hall, I. (2000). Pharmaceutical packaging technology. London and New York: Taylor & Francis, 459.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
